Infinity Stock Today

INFI -  USA Stock  

USD 0.62  0.01  1.59%

Market Performance
1 of 100
Odds Of Distress
Less than 6
Infinity Pharmaceuti is trading at 0.62 as of the 23rd of May 2022. This is a -1.59% down since the beginning of the trading day. The stock's open price was 0.63. Infinity Pharmaceuti has only a 6 % chance of going through financial distress over the next few years but had a somewhat weak performance during the last 90 days. Equity ratings for Infinity Pharmaceuti are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of January 2021 and ending today, the 23rd of May 2022. Click here to learn more.
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Infinity Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in Cambridge, Massachusetts. Infinity Pharmaceuti operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.. The company has 89.02 M outstanding shares of which 4.66 M shares are currently shorted by private and institutional investors with about 5.54 trading days to cover. More on Infinity Pharmaceuti
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

Infinity Pharmaceuti Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Infinity Pharmaceuti's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Infinity Pharmaceuti or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Infinity Pharmaceuti generated a negative expected return over the last 90 days
Infinity Pharmaceuti has high historical volatility and very poor performance
Infinity Pharmaceuti has some characteristics of a very speculative penny stock
Infinity Pharmaceuti was previously known as INFINITY PHARMACEUTICALS INC and was traded on NASDAQ Exchange under the symbol DPII.
The company reported the previous year's revenue of 1.86 M. Net Loss for the year was (45.26 M) with loss before overhead, payroll, taxes, and interest of (30.91 M).
Infinity Pharmaceuti currently holds about 80.73 M in cash with (40.62 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.9, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Infinity Pharmaceuti has a frail financial position based on the latest SEC disclosures
Infinity Pharmaceuti Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
Infinity Pharmaceuti SEC Filings
Infinity Pharmaceuti SEC Filings Security & Exchange Commission EDGAR Reports
Older SymbolDPII
ChairmanAdelene Perkins  (View All)
Average Analyst Recommendation
Analysts covering Infinity Pharmaceuti report their recommendations after researching Infinity Pharmaceuti's financial statements, talking to executives and customers, or listening in on Infinity Pharmaceuti's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Infinity Pharmaceuti. The Infinity consensus assessment is calculated by taking the average forecast from all of the analysts covering Infinity Pharmaceuti.
Strong Buy7 Opinions
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Infinity Pharmaceuti based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Infinity Pharmaceuti financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
 2 - FrailDetails
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares74.6 M85.6 M
Fairly Down
Slightly volatile
Weighted Average Shares Diluted74.6 M85.6 M
Fairly Down
Slightly volatile
Net Cash Flow from Operations(43.8 M)(40.6 M)
Significantly Down
Very volatile
Total Assets112.3 M84.8 M
Significantly Up
Slightly volatile
Total Liabilities61.7 M63.2 M
Fairly Down
Current Assets106.6 M82.3 M
Significantly Up
Slightly volatile
Current Liabilities17.4 M13.3 M
Significantly Up
Slightly volatile
Total Debt941.1 K917 K
Fairly Up
Slightly volatile
Gross Margin0.890.9
Fairly Down
Slightly volatile
Asset Turnover0.01950.019
Fairly Up
Slightly volatile
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Infinity Pharmaceuti's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong SellUndervalued
Financial Strength
Infinity Pharmaceuti's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Infinity Pharmaceuti's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Infinity Pharmaceuti's financial leverage. It provides some insight into what part of Infinity Pharmaceuti's total assets is financed by creditors.
Share Download
Share Download
By using current balance sheet information, investors can analyze the liability, assets, and equity on Infinity Pharmaceuti's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Infinity Pharmaceuti deploys its capital and how much of that capital is borrowed.
Infinity Pharmaceuti cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 1.44 M in liabilities with Debt to Equity (D/E) ratio of 0.07, which may suggest the company is not taking enough advantage from borrowing. Infinity Pharmaceuti has a current ratio of 6.07, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Infinity Pharmaceuti until it has trouble settling it off, either with new capital or with free cash flow. So, Infinity Pharmaceuti's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Infinity Pharmaceuti sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Infinity to invest in growth at high rates of return. When we think about Infinity Pharmaceuti's use of debt, we should always consider it together with cash and equity.

Operating Cash Flow

(43.82 Million)Share
Infinity Pharmaceuti (INFI) is traded on NASDAQ Exchange in USA. It is located in 1100 Massachusetts Avenue and employs 23 people. Infinity Pharmaceuti was previously known as INFINITY PHARMACEUTICALS INC and was traded on NASDAQ Exchange under the symbol DPII. Infinity Pharmaceuti is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with current market capitalization of 60.33 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Infinity Pharmaceuti's market, we take the total number of its shares issued and multiply it by Infinity Pharmaceuti's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Infinity Pharmaceuti conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 89.02 M outstanding shares of which 4.66 M shares are currently shorted by private and institutional investors with about 5.54 trading days to cover. Infinity Pharmaceuti currently holds about 80.73 M in cash with (40.62 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.9, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Infinity Pharmaceuti Probability Of Bankruptcy
Infinity Pharmaceuti secures a total of 89.02 Million outstanding shares. 30% of Infinity Pharmaceuti outstanding shares are owned by outside corporations. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulation than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or about to change. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.

Ownership Allocation (%)

Check Infinity Ownership Details

Infinity Stock Price Odds Analysis

What are Infinity Pharmaceuti's target price odds to finish over the current price? In reference to a normal probability distribution, the odds of Infinity Pharmaceuti jumping above the current price in 90 days from now is over 95.22%. The Infinity Pharmaceuti probability density function shows the probability of Infinity Pharmaceuti stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 2.193. This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Infinity Pharmaceuti will likely underperform. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Infinity Pharmaceuti is significantly underperforming DOW.
  Odds Below 0.62HorizonTargetOdds Above 0.62
4.76%90 days
Based on a normal probability distribution, the odds of Infinity Pharmaceuti to move above the current price in 90 days from now is over 95.22 (This Infinity Pharmaceuti probability density function shows the probability of Infinity Stock to fall within a particular range of prices over 90 days) .

Infinity Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Infinity Pharmaceuti that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Infinity Pharmaceuti's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Infinity Pharmaceuti's value.
InstituionSecurity TypeTotal SharesValue
Blackrock IncCommon Shares6.6 M7.5 M
Bvf IncCommon Shares6.4 M7.2 M
View Infinity Pharmaceuti Diagnostics

Infinity Pharmaceuti Historical Income Statement

Infinity Pharmaceuti Income Statement is one of the three primary financial statements used for reporting Infinity's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Infinity Pharmaceuti revenue and expense. Infinity Pharmaceuti Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Infinity Pharmaceuti Operating Expenses is most likely to decrease significantly in the upcoming years. The last year's value of Operating Expenses was reported at 46.94 Million. The current Revenues is estimated to increase to about 1.9 M, while Consolidated Income is projected to decrease to (48.8 M). View More Fundamentals

Infinity Stock Against Markets

Picking the right benchmark for Infinity Pharmaceuti stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Infinity Pharmaceuti stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Infinity Pharmaceuti is critical whether you are bullish or bearish towards Infinity Pharmaceuti at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Infinity Pharmaceuti without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Bollinger Bands Now


Bollinger Bands

Use Bollinger Bands indicator to analyze target price for a given investing horizon
All  Next Launch Module

Infinity Pharmaceuti Corporate Directors

Infinity Pharmaceuti corporate directors refer to members of an Infinity Pharmaceuti board of directors. The board of directors generally takes responsibility for the Infinity Pharmaceuti's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Infinity Pharmaceuti's board members must vote for the resolution. The Infinity Pharmaceuti board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Jeffrey Berkowitz - Independent DirectorProfile
Norman Selby - Lead Outside Independent DirectorProfile
Jose Baselga - Independent DirectorProfile
Michael Venuti - Independent DirectorProfile

Investing Infinity Pharmaceuti

You need to understand the risk of investing before taking a position in Infinity Pharmaceuti. The danger of trading Infinity Pharmaceuti is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Infinity Pharmaceuti is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Infinity Pharmaceuti. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Infinity Pharmaceuti is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Please see Risk vs Return Analysis. Note that the Infinity Pharmaceuti information on this page should be used as a complementary analysis to other Infinity Pharmaceuti's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Stock Screener module to find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Complementary Tools for Infinity Stock analysis

When running Infinity Pharmaceuti price analysis, check to measure Infinity Pharmaceuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infinity Pharmaceuti is operating at the current time. Most of Infinity Pharmaceuti's value examination focuses on studying past and present price action to predict the probability of Infinity Pharmaceuti's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Infinity Pharmaceuti's price. Additionally, you may evaluate how the addition of Infinity Pharmaceuti to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Is Infinity Pharmaceuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Infinity Pharmaceuti. If investors know Infinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Infinity Pharmaceuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Infinity Pharmaceuti is measured differently than its book value, which is the value of Infinity that is recorded on the company's balance sheet. Investors also form their own opinion of Infinity Pharmaceuti's value that differs from its market value or its book value, called intrinsic value, which is Infinity Pharmaceuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Infinity Pharmaceuti's market value can be influenced by many factors that don't directly affect Infinity Pharmaceuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Infinity Pharmaceuti's value and its price as these two are different measures arrived at by different means. Investors typically determine Infinity Pharmaceuti value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Infinity Pharmaceuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.